Heterogeneity of triple-negative breast carcinomas

Oncologie

Volumn 14, Issue 1, 2012, Pages 28-30

  Menard S ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Basal tumors; Classification; Prognosis; Triplenegative tumors

Indexed keywords

BEVACIZUMAB; SUNITINIB;

ARTICLE; CANCER CLASSIFICATION; CANCER PROGNOSIS; CANCER THERAPY; GENE MUTATION; HUMAN; TRIPLE NEGATIVE BREAST CANCER;

EID: 84861829838     PISSN: 12923818     EISSN: 17652839     Source Type: Journal    
DOI: 10.1007/s10269-011-2104-y     Document Type: Article

References (18)

1. Badve S, Dabbs DJ, Schnitt SJ, et al. (2011) Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists. Modern Pathol 24: 157-67
2. Carey LA, Sharpless NE (2011) PARP and cancer-if it's broke, don't fix it. N Engl J Med 364(3): 277-9
3. Cheang MC, Voduc D, Bajdik C, et al. (2008) Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype. Clin Cancer Res 14(5): 1368-76 (Pubitemid 351413917)
4. De Laurentiis M, Cianniello D, Caputo R, et al (2010) Treatment of triple negative breast cancer (TNBC): current options and future perspectives. Cancer Treat Rev 36(Suppl 3): S80-S6
5. Ebos JM, Lee CR, Cruz-Munoz W, et al. (2009) Accelerated metastasis after shortterm treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell 15: 232-9
6. Foulkes WD, Smith IE, Reis-Filho JS (2010) Triple-negative breast cancer. N Engl J Med 363(20): 1938-48
7. Hudis CA, Gianni L (2011) Triple-negative breast cancer: an unmet medical need. Oncologist 16(Suppl 1): 1-11
8. Irshad S, Ellis P, Tutt A (2011) Molecular heterogeneity of triple-negative breast cancer and its clinical implications. Curr Opin Oncol 23(6): 566-77
9. Lee E, Kean-Cowdin R, Ma H, et al. (2011) Characteristics of triple-negative breast cancer in patients with a BRCA1 mutation: results from a population-based study of young women. J Clin Oncol 29(33): 4373-80. Epub 2011 Oct 17
10. Lehmann BD, Bauer JA, Chen X, et al (2011) Identification of human triplenegative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest 121(7): 2750-67
11. Oakman C, Moretti E, Pacini G, et al. (2011) Triple negative breast cancer: a heterogeneous subgroup defined by what it is not. Eur J Cancer 47(Suppl 3): S370-S2
12. Patani N, Barbashina V, Lambros MB, et al (2011) Direct evidence for concurrent morphological and genetic heterogeneity in an invasive ductal carcinoma of triple-negative phenotype. J Clin Pathol 64(9): 822-8
13. Perou CM, Sørlie T, Eisen MB, et al. (2000) Molecular portraits of human breast tumours. Nature 406(6797): 747-52
14. Perou CM (2011) Molecular stratification of triple-negative breast cancers. Oncologist 16(Suppl 1): 61-70
15. Prat A, Perou CM (2011) Deconstructing the molecular portraits of breast cancer. Mol Oncol 5: 5-23
16. Rody A, Karn T, Liedtke C, et al (2011) A clinically relevant gene signature in triple negative and basal-like breast cancer. Breast Cancer Res 13(5): R97
17. Sun T, Aceto N, Meerbrey KL, et al. (2011) Activation of multiple proto-oncogenic tyrosine kinases in breast cancer via loss of the PTPN12 phosphatase. Cell 144(5): 703-18
18. Tagliabue E, Agresti R, Carcangiu ML, et al (2003) Role of HER2 in woundinduced breast carcinoma proliferation. Lancet 362: 527-33 (Pubitemid 36980657)